1. Home
  2. EVF vs ENTA Comparison

EVF vs ENTA Comparison

Compare EVF & ENTA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • EVF
  • ENTA
  • Stock Information
  • Founded
  • EVF 1998
  • ENTA 1995
  • Country
  • EVF United States
  • ENTA United States
  • Employees
  • EVF N/A
  • ENTA N/A
  • Industry
  • EVF Investment Managers
  • ENTA Biotechnology: Pharmaceutical Preparations
  • Sector
  • EVF Finance
  • ENTA Health Care
  • Exchange
  • EVF Nasdaq
  • ENTA Nasdaq
  • Market Cap
  • EVF 112.0M
  • ENTA 127.8M
  • IPO Year
  • EVF N/A
  • ENTA 2013
  • Fundamental
  • Price
  • EVF $6.14
  • ENTA $6.28
  • Analyst Decision
  • EVF
  • ENTA Buy
  • Analyst Count
  • EVF 0
  • ENTA 4
  • Target Price
  • EVF N/A
  • ENTA $19.50
  • AVG Volume (30 Days)
  • EVF 93.3K
  • ENTA 537.1K
  • Earning Date
  • EVF 01-01-0001
  • ENTA 02-05-2025
  • Dividend Yield
  • EVF 10.68%
  • ENTA N/A
  • EPS Growth
  • EVF N/A
  • ENTA N/A
  • EPS
  • EVF 0.94
  • ENTA N/A
  • Revenue
  • EVF N/A
  • ENTA $67,635,000.00
  • Revenue This Year
  • EVF N/A
  • ENTA $11.80
  • Revenue Next Year
  • EVF N/A
  • ENTA $3.99
  • P/E Ratio
  • EVF $6.74
  • ENTA N/A
  • Revenue Growth
  • EVF N/A
  • ENTA N/A
  • 52 Week Low
  • EVF $5.20
  • ENTA $5.70
  • 52 Week High
  • EVF $6.84
  • ENTA $17.80
  • Technical
  • Relative Strength Index (RSI)
  • EVF 33.11
  • ENTA 31.04
  • Support Level
  • EVF $6.13
  • ENTA $5.70
  • Resistance Level
  • EVF $6.24
  • ENTA $6.56
  • Average True Range (ATR)
  • EVF 0.05
  • ENTA 0.74
  • MACD
  • EVF -0.01
  • ENTA -0.11
  • Stochastic Oscillator
  • EVF 20.00
  • ENTA 14.91

About EVF Eaton Vance Senior Income Trust

Eaton Vance Senior Income Trust is a United States-based diversified, closed-end management investment company. Its investment objective is to provide a high level of current income consistent with the preservation of capital, by investing in senior, secured floating-rate loans. The trust invests in below-investment-grade floating-rate loans, which are considered speculative because of the credit risk of their issuers. Its portfolio of investment consists of aerospace and defense, automotive, beverage, building and development, business equipment and services, cable and satellite television, and other areas.

About ENTA Enanta Pharmaceuticals Inc.

Enanta Pharmaceuticals Inc is an American biotechnology company which uses robust, chemistry-driven approach and drug discovery capabilities to focus on the research and development of molecule drugs to cure viral infections and liver diseases. Uses virology and immunology method for curing the diseases. The targeted diseases are hepatitis C, hepatitis B, nonalcoholic steatohepatitis, and the respiratory syncytial virus. The novelty of company research is a specific direct-acting antiviral inhibitor against the hepatitis C virus. The company's inhibitors have been developed in collaboration with AbbVie. AbbVie markets the protease inhibitor, paritaprevir, while other inhibitors are in the pipeline.

Share on Social Networks: